Biotechnology Group Leader:

Drew Lowery, Ph.D.
Dr. Lowery has led and worked on projects representing a wide array of technologies, such as single molecule nucleic acid amplification and sequencing, pharmaceutical formulation and dosing, satiety hormones, microfludics integrated systems, and biofuel production, among others. He directs all biological sequence searching efforts and specializes in cost efficient strategies for complicated cases. Dr. Lowery launched the Accelerated Examination Support practice, where his searches have been favorable reviewed by the USPTO, leading to patent granting for his clients. Dr. Lowery holds a Ph.D. in Biochemistry from the Massachusetts Institute of Technology where he studied cancer signaling networks.

Project Managers:

David Adamovich, Ph.D.
Ph.D. in Biological and Biomedical Sciences, Harvard University
Expertise in microbiology, genomics, therapeutic formulations

Poy Theprungsirikul, B.S.
B.S. in Biomedical Engineering, Johns Hopkins University
Expertise in cell culture and differentiation, antibody engineering

Additional Expertise:

Vadim Demidov, Ph.D.
Ph.D. in Biophysics, Institute of Molecular Genetics of USSR Academy of Sciences
Expertise in PCR & sequencing methodologies, microfluidics

Jeannette Fiala, Ph.D.
Ph.D. in Biological Chemistry, Massachusetts Institute of Technology
Expertise in biomass processing, biofilm elimination, nutritional formulations, diagnostic assays & microarrays

Venkata Paruchuri, M.S
M.S in Biomedical Engineering, Johns Hopkins University
Expertise in antibodies & biological targets

Neha Suri, M.S.
M.S. in Biotechnology, University of Pennsylvania
Expertise in high-throughput screening, lipids, therapeutic proteins